A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers

by Oyoo George O, Kipkeu Chemtai, Jemutai Julie, Wenwa Ednah, Mwambingu Gabriel, Salim Amina, Anabwani Evelyn, Nyakundi Priscilla, Lodenyo Hudson, Bashraheil Mahfudh, Abdallah Ahmed M, Juma Rashid, Chilengi Roma, Muchohi Simon N, Kokwaro Gilbert, Niehues Tim, Lang Trudie, Nzila Alexis
Published 2011-03-01